Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB.
The DR-TB Scale-Up Treatment Action Team (DR-TB STAT) and Treatment Action Group (TAG) released a statement outlining practice-based recommendations for the optimal management of rifampicin-resistant/multidrug-resistant TB (RR/MDR-TB).
It is intended to help country programs implement the 2018 World Health Organization recommendations for the management of RR/MDR-TB and was developed based on field experience providing direct care for people living with RR/MDR-TB, engaging with TB programs, and listening to the perspectives from the TB community.
To download the statement, click here.